Focus research 2022 NoLymIT team
Consensus Classification (ICC) of Mature Lymphoid Neoplasms.
Camille Laurent and Pierre Brousset have joined the ICC Clinical Advisory Committee to update the diagnostic criteria for mature lymphoid neoplasms. Read the article
NoLymIT is a partner in the European TRANSCAN-3 BIALYMPH project
The NoLymIT team is a partner of BIALYMPH in the European research program TRANSCAN, coordinated by Dr Wolfgang Huber and including five research teams: UKHD Heidelberg, two Inserm teams (MOBIDIC from Université de Rennes/Inserm and NoLymIT from CRCT), University of Palermo and Eotvos Lorand Research Network & Biological Research Centre. The objective is to identify patients with follicular B lymphoma who may or may not respond to bispecific antibodies. The NoLymIT team will characterize immuno-escape mechanisms using multi-omics approaches in the lymph nodes of FL patients from the various clinical trials of the three major European cooperative groups: German Lymphoma Alliance (GLA), French Lymphoma Study Association (LYSA), and Italian Lymphoma Foundation (FIL). To find out more
To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here
Toulouse Cancer Research Center (Oncopole)
Toulouse - FR
CRCT-Oncopole Follow 1,433 1,279
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
;
🇬🇧Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. ImPact team @CordelierPierre article from @crctoncopole published in @CommsBio
➡️https://www.crct-inserm.fr/en/targeting-the-energy-production-process-in-pancreatic-cancer-cells-which-relies-on-an-enzyme-called-cytidine-deaminase-could-make-these-cells-more-vulnerable/
Contact us
+33 5 82 74 15 75
Want to join
the CRCT team ?
